Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Oct 06, 2022 | Buy | $1.29 | 29,743 | 38,368 | 59,743 | Oct 11, 2022, 05:05 PM | |
OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Oct 07, 2022 | Buy | $1.27 | 3,600 | 4,572 | 63,343 | Oct 11, 2022, 05:05 PM | |
OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Dec 02, 2021 | Buy | $1.39 | 10,000 | 13,900 | 30,000 | Dec 02, 2021, 05:09 PM | |
OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Apr 19, 2021 | Buy | $1.82 | 10,000 | 18,200 | 20,000 | Apr 20, 2021, 07:56 PM | |
OTLK | Outlook Therapeutics, Inc. | Haddadin Yezan Munther | Director | Sep 22, 2020 | Buy | $0.72 | 10,000 | 7,245 | 10,000 | Sep 22, 2020, 05:14 PM |